Drug Profile
Factor VIII - China Biologic Products
Alternative Names: Human coagulation factor VIII - China Biologics; Human coagulation factor VIII - Shandong TaibangLatest Information Update: 19 Nov 2021
Price :
$50
*
At a glance
- Originator China Biologic Products; Shandong Taibang Biological Products
- Class Antihaemorrhagics; Blood coagulation factors; Recombinant proteins
- Mechanism of Action Blood coagulation factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Haemophilia A
- Discontinued Haemorrhage
Most Recent Events
- 06 Aug 2013 Launched for Haemophilia A in China (IV) before August 2013